ArticleReviews in urology2018
Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication Comparison.
Article in Reviews in urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04081636 (Prospective, Randomized Study Comparing Transperineal and Transrectal Prostate Biopsy Efficacy and Complications), which is not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prospective, Randomized Study Comparing Transperineal and Transrectal Prostate Biopsy Efficacy and Complications (ProBE-PC Trial)
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.
- Transrectal vs transperineal prostate biopsy: a systematic review and meta-analysis.BJU international · 2026Pooled it
- Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis.Prostate cancer and prostatic diseases · 2024Pooled it
- The clinical utility of prostate MRI before biopsy.Nature reviews. Urology · 2026Review
- Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy.BJUI compass · 2026Article
- Periprostatic Abscess Extending to the Perineum Following Hydrogel Spacer Placement: A Case Report.IJU case reports · 2026Article
- Patient-reported outcome measures for pain and tolerability of transperineal prostate biopsy under local anaesthesia using the PrecisionPoint™ transperineal access system: A prospective study for a real-world patient experience.Investigative and clinical urology · 2025Article
- Choosing the path: insights into transperinealTranslational andrology and urology · 2025Article
- Development and validation of a nomogram model for predicting acute urinary retention after transrectal prostate biopsy.Translational andrology and urology · 2025Article
- The risk prediction model for acute urine retention after perineal prostate biopsy based on the LASSO approach and Boruta feature selection.Frontiers in oncology · 2025Article
- Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging.Prostate international · 2024Article
- Targeted Prostate Biopsy: How, When, and Why? A Systematic Review.Diagnostics (Basel, Switzerland) · 2024Review
- A Detailed Clinical Case of Localized Prostate Tumors Treated with Nanoparticle-Assisted Sub-Ablative Laser Ablation.Nanomaterials (Basel, Switzerland) · 2024Article
- Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study.Cancer medicine · 2024Article
- Risk factors for infection and acute urinary retention following transperineal prostate biopsy.International urology and nephrology · 2024Article
- Ultrasound-guided transperineal vs transrectal prostate biopsy: A meta-analysis of diagnostic accuracy and complication rates.Open medicine (Warsaw, Poland) · 2024Article
- Utilizing a Questionnaire to Implement a Risk-based Antibiotic Prophylaxis Protocol for Transrectal Prostate Biopsy.Urology · 2023Article
- Ipsilateral hemigland prostate biopsy may underestimate cancer burden in patients with unilateral mpMRI-visible lesions.Abdominal radiology (New York) · 2023Article
- Feasibilities and outcomes of patients treated with simultaneous prostate biopsy and general urological surgeries.Experimental and therapeutic medicine · 2023Article
- Selective biomarkers for inflammation and infection are associated with post-operative complications following transperineal template prostate biopsy (TTPB): a single-centre observational clinical pilot-study.European journal of medical research · 2022Observational
- The Effect of Different Types of Prostate Biopsy Techniques on Post-Biopsy Infectious Complications.The Journal of urology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herein, the authors compare morbidity in men who underwent both transrectal ultrasound-guided (TRUS) prostate biopsy and transperineal mapping biopsy (TPMB) at two institutions with extensive experience in both procedures. We also identified strategies and predictive factors to reduce morbidity for both procedures. In our study, 379 men from two institutions, of which 265 (69.9%) had a prior TRUS-guided biopsy, also had TPMB performed via a template with biopsies taken at 5-mm intervals. Men in the TRUS group had a median of 12 cores sampled whereas the TPMB group had 51.5 (range, 16-151). The median biopsy density was 1.1 core/cc prostate volume. Median age and prostate-specific antigen (PSA) level were 65 years (range, 34-86) and 5.5 ng/mL (range, 0.02-118). Of these men, 11 of 265 (4.2%) who had TRUS biopsy developed urinary tract infection compared with 3 of 379 (0.79%) of those with mapping biopsy. Infection was 14.8% in TRUS biopsy group with 13 or more cores versus 2.9% in those with 12 or less (OR, 5.8; 95% CI, 1.6-21.2;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.